|
60
|
234
|
2bohB |
Crystal structure of factor xa in complex with compound "1" |
|
61
|
240
|
2bdbA |
Porcine pancreatic elastase complexed with asn-pro-ile and ala-ala at ph 5.0 |
|
34
|
199
|
2bhgA |
3c protease from type a10(61) foot-and-mouth disease virus |
|
61
|
240
|
2bd9A |
Porcine pancreatic elastase complexed with beta-casomorphin-7 and arg-phe at ph 5.0 (50 min soak) and immersed in ph 9 buffer for 28 seconds (2nd ph jump) |
|
53
|
223
|
2btcE |
Bovine trypsin in complex with squash seed inhibitor (cucurbita pepo trypsin inhibitor ii) |
|
63
|
240
|
2blqA |
Elastase after a high dose x-ray "burn" |
|
47
|
223
|
2bdhA |
Human kallikrein 4 complex with zinc and p-aminobenzamidine |
|
46
|
223
|
2bdiA |
Human kallikrein 4 complex with cobalt and p-aminobenzamidine |
|
62
|
240
|
2bd5A |
Porcine pancreatic elastase complexed with beta-casomorphin-7 and lys-ser at ph 5 and immersed in ph 9 buffer for 30 seconds |
|
56
|
207
|
2as9A |
Functional and structural characterization of spl proteases from staphylococcus aureus |
|
59
|
234
|
2bmgB |
Crystal structure of factor xa in complex with 50 |
|
62
|
240
|
2bdcA |
Porcine pancreatic elastase complexed with asn-pro-ile at ph 5.0 |
|
88
|
394
|
2b9lA |
Crystal structure of prophenoloxidase activating factor-ii from the beetle holotrichia diomphalia |
|
63
|
240
|
2bloA |
Elastase before a high dose x-ray "burn" |
|
50
|
223
|
2bdgA |
Human kallikrein 4 complex with nickel and p-aminobenzamidine |
|
60
|
240
|
2bd3A |
Porcine pancreatic elastase complexed with beta-casomorphin-7 and lys-ala-nh2 at ph 5.0 |
|
62
|
240
|
2bd2A |
Porcine pancreatic elastase complexed with beta-casomorphin-7 and arg-phe at ph 5.0 |
|
56
|
223
|
2blwA |
Trypsin after a high dose x-ray "burn" |
|
60
|
240
|
2bd7A |
Porcine pancreatic elastase complexed with beta-casomorphin-7 and arg-phe at ph 5.0 (50 min soak) |
|
78
|
286
|
2bdyA |
Thrombin in complex with inhibitor |
|
50
|
254
|
2b8oH |
Crystal structure of glu-gly-arg-chloromethyl ketone-factor viia/soluble tissue factor complex |
|
50
|
225
|
2asuB |
Crystal structure of the beta-chain of hgfl/msp |
|
61
|
240
|
2bd8A |
Porcine pancreatic elastase complexed with beta-casomorphin-7 and arg-phe at ph 5.0 (50 min soak) and immersed in ph 9 buffer for 30 seconds |
|
62
|
240
|
2bb4A |
Porcine pancreatic elastase complexed with beta-casomorphin-7 and asp-phe at ph 5.0 |
|
39
|
182
|
2b0fA |
Nmr structure of the human rhinovirus 3c protease (serotype 14) with covalently bound ace-lealfq-ethylpropionate inhibitor |
|
54
|
231
|
2aiqA |
Crystal structure of benzamidine-inhibited protein c activator from the venom of copperhead snake agkistrodon contortrix contortrix |
|
52
|
223
|
2aggX |
Succinyl-aapk-trypsin acyl-enzyme at 1.28 a resolution |
|
56
|
223
|
2aywA |
Crystal structure of the complex formed between trypsin and a designed synthetic highly potent inhibitor in the presence of benzamidine at 0.97 a resolution |
|
55
|
223
|
2agiX |
The leupeptin-trypsin covalent complex at 1.14 a resolution |
|
57
|
254
|
2aerH |
Crystal structure of benzamidine-factor viia/soluble tissue factor complex. |
|
57
|
259
|
2b5tB |
2.1 angstrom structure of a nonproductive complex between antithrombin, synthetic heparin mimetic sr123781 and two s195a thrombin molecules |
|
79
|
299
|
2ampA |
Crystal structure of porcine transmissible gastroenteritis virus mpro in complex with an inhibitor n1 |
|
56
|
257
|
2anmH |
Ternary complex of an orally active thrombin inhibitor with human thrombin and a c-terminal hirudin derived exo-sit inhibitor |
|
55
|
231
|
2aipA |
Crystal structure of native protein c activator from the venom of copperhead snake agkistrodon contortrix contortrix |
|
50
|
259
|
2afqB |
1.9 angstrom crystal structure of wild-type human thrombin in the sodium free state |
|
46
|
238
|
2anyA |
Expression, crystallization and the three-dimensional structure of the catalytic domain of human plasma kallikrein: implications for structure-based design of protease inhibitors |
|
55
|
223
|
2ah4X |
Guanidinobenzoyl-trypsin acyl-enzyme at 1.13 a resolution |
|
52
|
254
|
2aeiH |
Crystal structure of a ternary complex of factor viia/tissue factor and 2-[[6-[3-(aminoiminomethyl)phenoxy]-3,5-difluro-4-[(1-methyl-3-phenylpropyl)amino]-2-pyridinyl]oxy]-benzoic acid |
|
54
|
257
|
2ankH |
Orally active thrombin inhibitors in complex with thrombin and an exosite decapeptide |
|
39
|
155
|
2ahmE |
Crystal structure of sars-cov super complex of non-structural proteins: the hexadecamer |
|
83
|
309
|
2amdA |
Crystal structure of sars_cov mpro in complex with an inhibitor n9 |
|
52
|
238
|
2anwA |
Expression, crystallization and three-dimensional structure of the catalytic domain of human plasma kallikrein: implications for structure-based design of protease inhibitors |
|
83
|
303
|
2amqA |
Crystal structure of sars_cov mpro in complex with an inhibitor n3 |
|
86
|
302
|
2alvA |
X-ray structural analysis of sars coronavirus 3cl proteinase in complex with designed anti-viral inhibitors |
|
52
|
198
|
2alpA |
Refined structure of alpha-lytic protease at 1.7 angstroms resolution. analysis of hydrogen bonding and solvent structure |
|
56
|
223
|
2ageX |
Succinyl-aapr-trypsin acyl-enzyme at 1.15 a resolution |
|
52
|
237
|
1zhmA |
Crystal structure of the catalytic domain of the coagulation factor xia in complex with benzamidine (s434a-t475a-k437 mutant) |
|
39
|
181
|
2a4qA |
Hcv ns3 protease with ns4a peptide and a covalently bound macrocyclic ketoamide compound. |
|
54
|
254
|
2a2qH |
Complex of active-site inhibited human coagulation factor viia with human soluble tissue factor in the presence of ca2+, mg2+, na+, and zn2+ |
|
53
|
238
|
1zskA |
Crystal structure of the catalytic domain of coagulation factor xi in complex with 6-carbamimidoyl-4-(3-hydroxy-2-methyl-benzoylamino)-naphthalene-2-carboxylic acid methyl ester |
